SCHEMBL8425964

SCHEMBL8425964

C[C](C)CSc1nc2ccccc2[nH]1

nearest known ligand 0.79

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.79
HPGD P15428 1/20 0.79
KMT2A Q03164 3/20 0.71
BCHE P06276 1/20 0.69
EPHX2 P34913 1/20 0.66
RAB9A P51151 9/20 0.64
NPC1 O15118 8/20 0.62
POLB P06746 3/20 0.60
NR4A1 P22736 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
MEN1 O00255 2/20 0.59
AR P10275 1/20 0.59
MPO P05164 1/20 0.59
HCRTR1 O43613 1/20 0.59
MAPT P10636 1/20 0.59
HSD17B10 Q99714 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8797365 0.89 KMT2A (0.75) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL14304382 0.85 KMT2A (0.79) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL29770390 0.83 KMT2A (1.00) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL3515244 0.83 KMT2A (1.00) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL8251328 0.83 KMT2A (0.77) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL11269102 0.82 POLB (0.72) SMN1; SMN2HPGDKMT2APOLBTDP1
SCHEMBL7298254 0.82 EPHX2 (0.75) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL7998438 0.82 BCHE (0.73) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL31175737 0.82 BCHE (0.73) SMN1; SMN2HPGDKMT2ABCHEEPHX2
SCHEMBL15474114 0.82 KMT2A (0.75) SMN1; SMN2HPGDKMT2ABCHEEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942641-A TREATMENT OF ALZHEIMER'S DISEASE, NERVOUS SYSTEM DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-24 US disclosed
EP-0655992-B1 FLUORENONE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND CENTRAL OR PERIPHERAL NERVE DEGENERATION REPAIR AND PROTECTIVE AGENT OTSUKA PHARMA CO LTD (JP) 1998-11-04 EP disclosed
EP-0791570-A1 Fluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-08-27 EP disclosed
EP-0655992-A1 FLUORENONE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND CENTRAL OR PERIPHERAL NERVE DEGENERATION REPAIR AND PROTECTIVE AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-06-07 EP disclosed
WO-1995000468-A1 FLUORENONE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND CENTRAL OR PERIPHERAL NERVE DEGENERATION REPAIR AND PROTECTIVE AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-01-05 WO disclosed